Award
National Institute on Drug Abuse 11320905
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
Recipient
Comfort Ahenkan Boateng
Award Amount
$447,000.00
Ceiling
$447,000.00
Awarded
March 23, 2026
Identifier
11320905
Award to develop selective ligands for dopamine D4 receptor variants to support research on neuropsychiatric and substance use disorders, funded by NIH for $447,000 in 2026.
Description
The project aims to develop selective ligands for D4 receptor variants to aid in understanding their role in neuropsychiatric disorders and substance use disorders. The project involves computational modeling and rational drug design. The award is for a single year, starting in 2026, with a total budget of $447,000. The primary investigator is Comfort Ahenkan Boateng, an Associate Professor at High Point University.